These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12759238)

  • 1. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer.
    Furukawa T; Sunamura M; Motoi F; Matsuno S; Horii A
    Am J Pathol; 2003 Jun; 162(6):1807-15. PubMed ID: 12759238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer.
    Furukawa T; Kanai N; Shiwaku HO; Soga N; Uehara A; Horii A
    Oncogene; 2006 Aug; 25(35):4831-9. PubMed ID: 16532023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.
    Magi-Galluzzi C; Mishra R; Fiorentino M; Montironi R; Yao H; Capodieci P; Wishnow K; Kaplan I; Stork PJ; Loda M
    Lab Invest; 1997 Jan; 76(1):37-51. PubMed ID: 9010448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis.
    Loda M; Capodieci P; Mishra R; Yao H; Corless C; Grigioni W; Wang Y; Magi-Galluzzi C; Stork PJ
    Am J Pathol; 1996 Nov; 149(5):1553-64. PubMed ID: 8909245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas.
    Furukawa T; Fujisaki R; Yoshida Y; Kanai N; Sunamura M; Abe T; Takeda K; Matsuno S; Horii A
    Mod Pathol; 2005 Aug; 18(8):1034-42. PubMed ID: 15832194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells.
    Kusumoto M; Ogawa T; Mizumoto K; Ueno H; Niiyama H; Sato N; Nakamura M; Tanaka M
    Clin Cancer Res; 1999 Aug; 5(8):2140-7. PubMed ID: 10473098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
    Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
    Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of DUSP6 by hypermethylation in human pancreatic cancer.
    Xu S; Furukawa T; Kanai N; Sunamura M; Horii A
    J Hum Genet; 2005; 50(4):159-167. PubMed ID: 15824892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-translational regulation of the ERK phosphatase DUSP6/MKP3 by the mTOR pathway.
    Bermudez O; Marchetti S; Pagès G; Gimond C
    Oncogene; 2008 Jun; 27(26):3685-91. PubMed ID: 18223677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway.
    Xu Q; Konta T; Nakayama K; Furusu A; Moreno-Manzano V; Lucio-Cazana J; Ishikawa Y; Fine LG; Yao J; Kitamura M
    Free Radic Biol Med; 2004 Apr; 36(8):985-93. PubMed ID: 15059639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1beta and glucocorticoids.
    Toh ML; Yang Y; Leech M; Santos L; Morand EF
    Arthritis Rheum; 2004 Oct; 50(10):3118-28. PubMed ID: 15476200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
    Hutter D; Chen P; Barnes J; Liu Y
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo.
    Iuliano R; Trapasso F; Le Pera I; Schepis F; Samà I; Clodomiro A; Dumon KR; Santoro M; Chiariotti L; Viglietto G; Fusco A
    Cancer Res; 2003 Feb; 63(4):882-6. PubMed ID: 12591742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice.
    Marchetti S; Gimond C; Roux D; Gothié E; Pouysségur J; Pagès G
    J Cell Physiol; 2004 Jun; 199(3):441-50. PubMed ID: 15095291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transcriptional regulation of the DUSP6/MKP-3 phosphatase by MEK/ERK signaling and hypoxia.
    Bermudez O; Jouandin P; Rottier J; Bourcier C; Pagès G; Gimond C
    J Cell Physiol; 2011 Jan; 226(1):276-84. PubMed ID: 20665674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
    Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
    Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feedback regulation of DUSP6 transcription responding to MAPK1 via ETS2 in human cells.
    Furukawa T; Tanji E; Xu S; Horii A
    Biochem Biophys Res Commun; 2008 Dec; 377(1):317-20. PubMed ID: 18848526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2.
    Yip-Schneider MT; Lin A; Marshall MS
    Biochem Biophys Res Commun; 2001 Feb; 280(4):992-7. PubMed ID: 11162624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model.
    Yanagie H; Tanabe T; Sumimoto H; Sugiyama H; Matsuda S; Nonaka Y; Ogiwara N; Sasaki K; Tani K; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 May; 63(4):275-86. PubMed ID: 18657378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of mitogen-activated protein kinase (MAPK) phosphatase-1 by anthracyclines contributes to their antiapoptotic activation of p44/42-MAPK.
    Small GW; Somasundaram S; Moore DT; Shi YY; Orlowski RZ
    J Pharmacol Exp Ther; 2003 Dec; 307(3):861-9. PubMed ID: 14557375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.